Yamazaki K, Yamanaka T, Shiozawa M, Manaka D, et al. Oxaliplatin-Based Adjuvant Chemotherapy Duration (3 vs. 6 Months) for High-Risk Stage II Colon Cancer: The Randomized Phase 3 ACHIEVE-2 Trial. Ann Oncol 2020 Oct 26. pii: S0923-7534(20)42983.
PMID: 33121997